Board and Executive Moves-Event Announcements-Financial Results
CANADIAN WEEKLY STOCK REPORT
Medicenna Therapeutics Corp. (TSX:MDNA), Canada's 12th largest Biotechnology company by market cap, has dropped 21.0c (or 4.1%) in the past week to close at CAD4.86. Compared with the S&P/TSX 60 Index which fell 1.6 points (or 0.1%) in the week, this represented a relative price change of -4.0%.
In the Canadian market of 1,620 stocks and 58 units traded today, the stock has a 6-month relative strength of 15 indicating it is trailing 85.0% of the market.
The price ranged between a low of 4.83 on Thursday, Dec 17 and a high of 5.07 on Friday, Dec 11. In the past week the market cap has declined by CAD10.3 million ($8.1 million) to CAD237.8 mi...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
